Schrödinger's Software Transition Looks Strategic on Paper but Investors Want Proof It Works

Schrodinger Inc (SDGR) reports first-quarter 2026 earnings tomorrow, May 5, after market close, with analysts expecting a loss of $0.56 per share. The central question is whether the computational drug discovery platform provider can sustain the dramatic momentum from Q4 2025, when it delivered a stunning profit of $0.44 per share that shattered expectations, or if that quarter represented a one-time milestone rather than a sustainable inflection point.

Part 1: Earnings Preview

Schrodinger operates a computational platform that accelerates drug discovery and materials design, combining physics-based software with AI-driven workflows to help pharmaceutical and industrial clients identify promising molecular candidates faster and more cost-effectively. The company generates revenue through software subscriptions and collaborative drug discovery partnerships.

For the quarter ending March 31, 2026, analysts expect SDGR to report a loss of $0.56 per share on revenue of approximately $48.96 million—representing a 43.87% sequential decline from Q4's $87.23 million. Compared to the same quarter last year, when SDGR posted a loss of $0.82 per share, the consensus estimate implies 31.71% year-over-year improvement in profitability. The most recently reported quarter (Q4 2025) delivered actual EPS of $0.44, marking the company's first profitable quarter and exceeding estimates by an extraordinary 438.46%.

Three key themes define this earnings story heading into the release:

Sustainability of Q4's Profitability Breakthrough: Q4 2025's surprise profit represented a watershed moment for SDGR, but investors are questioning whether it reflected sustainable business model improvements or timing-related revenue concentration from partnership milestones. The return to expected losses in Q1 suggests analysts view Q4 as an outlier rather than a new baseline.

Software Revenue Stability vs. Partnership Lumpiness: Schrodinger's business model combines recurring software subscriptions with milestone-driven drug discovery collaborations. The sharp sequential revenue decline projected for Q1 highlights the inherent volatility in partnership revenue, making the stability and growth trajectory of the software segment critical for valuation.

Path to Consistent Profitability: With full-year 2026 estimates calling for a loss of $1.25 per share (improving to $1.04 in 2027), the market is focused on management's commentary around operating leverage, R&D investment priorities, and the timeline for achieving sustainable profitability beyond one-off partnership windfalls.

Analyst commentary ahead of the release reflects cautious optimism tempered by valuation concerns. The wide dispersion in Q1 estimates—ranging from a loss of $0.59 to $0.50—underscores uncertainty around partnership timing and operating expense management during what is typically a seasonally weaker quarter for the company.

Part 2: Historical Earnings Performance

Schrodinger has demonstrated a clear pattern of exceeding analyst expectations over the past four quarters, though the magnitude of surprises has varied dramatically. The company beat estimates in three of the last four quarters, with the most recent Q4 2025 result representing an extraordinary 438.46% positive surprise as SDGR delivered a profit of $0.44 against expectations for a $0.13 loss.

Prior to Q4's breakthrough, the trend showed steady improvement: Q3 2025 beat by 40.00% (reporting a $0.45 loss vs. $0.75 expected), and Q2 2025 exceeded estimates by 28.92% (posting a $0.59 loss vs. $0.83 expected). The only miss came in Q1 2025, when SDGR reported a $0.82 loss compared to the $0.71 consensus, representing a 15.49% negative surprise.

The pattern reveals a company that has consistently outperformed lowered expectations throughout 2025, culminating in Q4's dramatic profitability milestone. However, the return to expected losses for Q1 2026 suggests analysts are treating Q4 as an exceptional quarter rather than extrapolating that performance forward, likely due to the lumpy nature of partnership milestone revenues that can create significant quarterly volatility in a business model still scaling toward consistent profitability.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Schrodinger typically reports earnings after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full session to react to actual results.

Historical price behavior around earnings shows moderate volatility with an average absolute Day 0 move of 3.70% and Day +1 move of 3.43%, though individual quarters have produced significantly larger swings. The most dramatic reaction came in November 2024, when the stock surged 13.87% on Day 0 ahead of results, though it gave back ground the following session. More recently, the February 2026 report (Q4 2025's surprise profit) generated a 4.42% Day 0 gain followed by an 8.14% Day +1 rally, demonstrating sustained positive momentum when results significantly exceed expectations.

The data reveals asymmetric behavior: positive surprises tend to generate sustained follow-through (as seen in February 2026 and February 2025), while disappointments can trigger sharp reversals (November 2025's 5.67% Day +1 decline, May 2024's 8.19% drop). The average Day +1 range of 10.41% indicates substantial intraday volatility regardless of direction, suggesting options sellers have historically been well-compensated for taking on earnings risk. Investors should prepare for potential moves in the 8-12% range based on whether results and guidance align with, exceed, or fall short of the Street's reset expectations following Q4's exceptional performance.

Part 2.2: Options Market Expected Move

The options market is pricing an 13.51% expected move through the May 15 expiration (11 days out), which is significantly higher than the historical average Day +1 move of 3.43% but roughly in line with the 10.41% average Day +1 range. This elevated implied volatility of 120.45% suggests options traders are anticipating above-average post-earnings volatility, likely reflecting uncertainty about whether Q4's profitability can be sustained or if results will revert to the loss pattern seen in prior quarters.

Part 3: What Analysts Are Saying

Analysts maintain a bullish stance on Schrodinger with an average recommendation of 4.20 (between Buy and Strong Buy), though sentiment has deteriorated slightly from 4.27 one month ago. The current consensus includes 6 Strong Buy ratings and 4 Hold ratings among 10 analysts covering the stock, with no Sell or Strong Sell recommendations. Notably, the Strong Buy count declined from 7 to 6 over the past month, reflecting some caution following Q4's exceptional results.

The average price target of $21.33 implies 65.3% upside from the current price of $12.90, with individual targets ranging from a low of $13.00 (just 0.8% above current levels) to a high of $30.00 (representing 132.6% potential appreciation). This wide dispersion—spanning $17.00—underscores the divergent views on whether SDGR's computational platform can translate into sustainable profitability and justify a premium valuation, or whether the business model's partnership-driven lumpiness will continue to constrain consistent financial performance and limit multiple expansion.

Part 4: Technical Picture

Schrodinger enters earnings with a deteriorating technical picture that has shifted from extremely bearish to moderately bearish in recent weeks. The Barchart Technical Opinion currently shows a 56% Sell signal, representing a notable improvement from 96% Sell one week ago and 100% Sell one month ago, suggesting some stabilization after a prolonged downtrend.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal indicates near-term momentum remains negative despite recent stabilization
• Medium-term (50% Sell): Moderate sell signal suggests the intermediate-term trend has not yet reversed despite the stock's recent bounce
• Long-term (100% Sell): Strong sell signal reflects persistent weakness in the longer-term trend, with the stock trading well below its 100-day and 200-day moving averages

Trend Characteristics: The trend is characterized by Good strength but the Weakest direction, indicating that while the current technical pattern is well-defined, it remains firmly bearish heading into the earnings release.

The stock is trading at $12.90, positioned above its 5-day ($12.25), 10-day ($12.14), 20-day ($12.01), and 50-day ($12.03) moving averages, showing short-term momentum improvement. However, SDGR remains below its 100-day moving average of $14.07 and significantly below its 200-day moving average of $16.82, confirming the longer-term downtrend remains intact.

The technical setup heading into earnings is cautiously constructive in the very short term but remains challenged in the broader context. The recent bounce above all short-term moving averages suggests some stabilization and potential base-building, but the stock's position 23.3% below its 200-day moving average indicates substantial overhead resistance. The key technical question is whether earnings can provide a catalyst to reclaim the 100-day moving average at $14.07 and begin reversing the longer-term downtrend, or if disappointment will send the stock back toward recent lows. The improving short-term momentum provides a slightly better technical foundation than existed a month ago, but the overall setup remains fragile given the persistent long-term sell signals.